vs

Side-by-side financial comparison of Antero Midstream Corp (AM) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $291.1M, roughly 1.7× Antero Midstream Corp). Antero Midstream Corp runs the higher net margin — 41.5% vs -10.1%, a 51.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -7.3%). Antero Midstream Corp produced more free cash flow last quarter ($186.9M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 3.9%).

Antero Resources Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Denver, Colorado. The company's reserves are entirely in the Appalachian Basin and are extracted using hydraulic fracturing.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

AM vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.7× larger
CLOV
$487.7M
$291.1M
AM
Growing faster (revenue YoY)
CLOV
CLOV
+52.1% gap
CLOV
44.7%
-7.3%
AM
Higher net margin
AM
AM
51.6% more per $
AM
41.5%
-10.1%
CLOV
More free cash flow
AM
AM
$255.9M more FCF
AM
$186.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
3.9%
AM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AM
AM
CLOV
CLOV
Revenue
$291.1M
$487.7M
Net Profit
$120.7M
$-49.3M
Gross Margin
Operating Margin
60.9%
-10.1%
Net Margin
41.5%
-10.1%
Revenue YoY
-7.3%
44.7%
Net Profit YoY
2.1%
-123.2%
EPS (diluted)
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AM
AM
CLOV
CLOV
Q1 26
$291.1M
Q4 25
$297.0M
$487.7M
Q3 25
$294.8M
$496.6M
Q2 25
$305.5M
$477.6M
Q1 25
$291.1M
$462.3M
Q4 24
$287.5M
$337.0M
Q3 24
$269.9M
$331.0M
Q2 24
$269.8M
$356.3M
Net Profit
AM
AM
CLOV
CLOV
Q1 26
$120.7M
Q4 25
$51.9M
$-49.3M
Q3 25
$116.0M
$-24.4M
Q2 25
$124.5M
$-10.6M
Q1 25
$120.7M
$-1.3M
Q4 24
$111.2M
$-22.1M
Q3 24
$99.7M
$-9.2M
Q2 24
$86.0M
$7.4M
Gross Margin
AM
AM
CLOV
CLOV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
AM
AM
CLOV
CLOV
Q1 26
60.9%
Q4 25
33.8%
-10.1%
Q3 25
61.2%
-4.9%
Q2 25
61.0%
-2.2%
Q1 25
60.9%
-0.3%
Q4 24
61.8%
-6.4%
Q3 24
60.2%
-2.7%
Q2 24
56.6%
2.0%
Net Margin
AM
AM
CLOV
CLOV
Q1 26
41.5%
Q4 25
17.5%
-10.1%
Q3 25
39.3%
-4.9%
Q2 25
40.8%
-2.2%
Q1 25
41.5%
-0.3%
Q4 24
38.7%
-6.6%
Q3 24
37.0%
-2.8%
Q2 24
31.9%
2.1%
EPS (diluted)
AM
AM
CLOV
CLOV
Q1 26
$0.25
Q4 25
$0.11
Q3 25
$0.24
Q2 25
$0.26
Q1 25
$0.25
Q4 24
$0.23
Q3 24
$0.21
Q2 24
$0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AM
AM
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$180.4M
$78.3M
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$2.0B
$308.7M
Total Assets
$5.9B
$541.0M
Debt / EquityLower = less leverage
1.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AM
AM
CLOV
CLOV
Q1 26
$180.4M
Q4 25
$180.4M
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Total Debt
AM
AM
CLOV
CLOV
Q1 26
$3.2B
Q4 25
$3.2B
Q3 25
$3.0B
Q2 25
$3.0B
Q1 25
$3.1B
Q4 24
$3.1B
Q3 24
$3.2B
Q2 24
$3.2B
Stockholders' Equity
AM
AM
CLOV
CLOV
Q1 26
$2.0B
Q4 25
$2.0B
$308.7M
Q3 25
$2.1B
$340.9M
Q2 25
$2.1B
$344.2M
Q1 25
$2.1B
$336.1M
Q4 24
$2.1B
$341.1M
Q3 24
$2.1B
$342.2M
Q2 24
$2.1B
$324.9M
Total Assets
AM
AM
CLOV
CLOV
Q1 26
$5.9B
Q4 25
$5.9B
$541.0M
Q3 25
$5.7B
$559.7M
Q2 25
$5.7B
$575.0M
Q1 25
$5.8B
$583.7M
Q4 24
$5.8B
$580.7M
Q3 24
$5.8B
$653.0M
Q2 24
$5.8B
$674.2M
Debt / Equity
AM
AM
CLOV
CLOV
Q1 26
1.63×
Q4 25
1.63×
Q3 25
1.46×
Q2 25
1.45×
Q1 25
1.49×
Q4 24
1.47×
Q3 24
1.49×
Q2 24
1.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AM
AM
CLOV
CLOV
Operating Cash FlowLast quarter
$198.9M
$-66.9M
Free Cash FlowOCF − Capex
$186.9M
$-69.0M
FCF MarginFCF / Revenue
64.2%
-14.1%
Capex IntensityCapex / Revenue
11.1%
0.4%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AM
AM
CLOV
CLOV
Q1 26
$198.9M
Q4 25
$255.5M
$-66.9M
Q3 25
$212.8M
$12.1M
Q2 25
$265.2M
$5.4M
Q1 25
$198.9M
$-16.3M
Q4 24
$232.7M
$34.8M
Q3 24
$184.9M
$50.0M
Q2 24
$215.8M
$44.8M
Free Cash Flow
AM
AM
CLOV
CLOV
Q1 26
$186.9M
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$184.3M
$49.6M
Q2 24
$147.2M
$44.4M
FCF Margin
AM
AM
CLOV
CLOV
Q1 26
64.2%
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
68.3%
15.0%
Q2 24
54.6%
12.5%
Capex Intensity
AM
AM
CLOV
CLOV
Q1 26
11.1%
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.0%
0.5%
Q3 24
0.2%
0.1%
Q2 24
25.4%
0.1%
Cash Conversion
AM
AM
CLOV
CLOV
Q1 26
1.65×
Q4 25
4.92×
Q3 25
1.84×
Q2 25
2.13×
Q1 25
1.65×
Q4 24
2.09×
Q3 24
1.85×
Q2 24
2.51×
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AM
AM

Gathering and compression–Antero Resources$238.0M82%
Other$52.3M18%
Water handling–third party$505.0K0%
Gathering and compression–third party$295.0K0%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons